Skip to content
Investing

Eramet Rights Issue: What Shareholders Can Do After Shares Close Ex-Rights at €18.77

Eramet shares closed at €18.77 on Monday, their first day ex-rights in a €500m rights issue priced at €14.49. Rights trade until 25 November and lapse on 27 November.

A loaded haul truck driving between ore stockpiles at an Eramet manganese operation in Gabon
Photo: Eramet

Eramet shares closed at €18.77 on Monday 16 November, their first day of trading without the rights attached to the French miner's €500m rights issue. Most of the drop from Friday's €32.92 was the value of those rights coming off the price, but the stock also fell a further 17.89% on top. Shareholders now have until Wednesday 25 November to sell their rights and until Friday 27 November to use them.

Eramet's rights issue in numbers

  • €14.49 price of each new share, six for every five already held
  • €18.77 Eramet's closing share price on Monday 16 November
  • 64.35% of the issue committed by the French State, about €321.7m

Monday's fall was two moves in one

Eramet closed at €32.92 on Friday 13 November, down 10.64% on the day the issue was announced, according to Boursorama's price data. On Monday it opened at €21.72 and finished at €18.77.

The first part of that gap was arithmetic. Every Eramet share carried one preferential subscription right, a ticket that lets its holder buy new shares at a discount. On Monday the ticket was cut off and began trading on its own. The theoretical ex-rights price, the value a share should have once the right is gone, comes to about €22.87 from Friday's close: five old shares at €32.92 plus six new ones at €14.49, divided by eleven.

Boursorama set Monday's reference price at €22.86, in line with that sum, and measured the day's move against it. That is where the 17.89% fall comes from. So the detachment explains about €10 of the drop. The other €4.09 a share was a real fall in the market price.

Aerial view of the floating dredge and concentrator at Eramet's Grande Côte mineral sands mine in Senegal.
Aerial view of the floating dredge and concentrator at Eramet's Grande Côte mineral sands mine in Senegal. Photo: Eramet
Eramet in the three months to 16 November 2026. Daily closing prices from exchange data.
Eramet in the three months to 16 November 2026. Daily closing prices from exchange data.

The terms are six new shares for every five

Eramet is raising €499,992,722.46 by issuing 34,506,054 new shares, more than the 28,755,047 it has today, according to its 13 November release. Five rights buy six new shares at €14.49 each. That price was a 62.34% discount to the 11 November close of €38.48, and Eramet put the theoretical value of each right at €13.09 on that basis.

At Monday's close, a right's theoretical value was about €5.14: the €4.28 gap between the share price and the €14.49 subscription price, multiplied by 1.2 because each right buys 1.2 new shares. That is a calculation, not a quote. The rights trade on Euronext Paris under their own code, ISIN FR001401C5C5, and their market price can differ.

DateWhat happens
Friday 13 NovemberLast day to buy shares that carry rights
Monday 16 NovemberShares trade ex-rights, rights start trading
Wednesday 18 NovemberSubscription opens
Wednesday 25 NovemberLast day to buy or sell rights
Friday 27 NovemberSubscription closes, unused rights lapse
Wednesday 2 DecemberResults announced
Friday 4 DecemberNew shares delivered and listed

The French State steps in as the Duval family steps back

The State owns 27.13% of Eramet through FSI-Equation, a company it owns that acts for its shareholding agency, the APE. It has committed €321.7m, or 64.35% of the issue, according to the prospectus summary. It will subscribe in line with its stake and also buy every right held by Sorame and CEIR, the Duval family holding companies that own 37.22%, at a 5% discount to their theoretical value, then use them. The Duval companies will buy no new shares.

After the deal the State will hold 47.43% of the capital and 39.76% of the voting rights, the prospectus summary says, making it the largest shareholder. A bank syndicate led by ABN AMRO, BofA Securities, Natixis and Société Générale has agreed to underwrite the rest, up to €178.3m.

The money goes to debt. Net debt, excluding the New Caledonian nickel business SLN, stood at €2,046m at 30 June 2026, and adjusted leverage, which compares that debt with a year's adjusted operating earnings, was 4.5 times. Eramet is aiming for below 3 times by the end of December and has promised no dividend until leverage drops below 1 time. Christel Bories, the chair and chief executive, told Zonebourse it was "une bonne opération qui redonne de vraies perspectives au groupe", a good deal that gives the group real prospects again.

Shareholders have three choices

Subscribe. Five rights plus €86.94 buy six new shares. A holder of 100 shares receives 100 rights, which buy 120 new shares for €1,738.80. Eramet also accepts orders for extra shares beyond that entitlement, though these can be scaled back if demand is high. Leftover rights that do not make up a block of five can be sold on Euronext Paris.

Sell the rights. The rights can be sold on Euronext Paris until the close on Wednesday 25 November. The cash is meant to make up for dilution, the shrinking of each old share's claim on the company as new shares arrive. A shareholder who owns 1% today and does not subscribe will own 0.45% afterwards, according to Eramet.

Do nothing. Unused rights lapse automatically at the close of trading on Friday 27 November, the company says. The holder is diluted and gets nothing for the rights.

Brokers may set earlier cut-offs than Eramet's dates because of their processing times, the company warns. The public offer is open in France only, so readers who hold Eramet through a broker abroad should ask what their account allows.

Questions and answers

What is an Eramet subscription right worth?

In theory, 1.2 times the gap between the share price and the €14.49 subscription price. With the shares at €18.77 on Monday 16 November, that was about €5.14 per right; the traded price can differ.

When does the Eramet rights issue close?

Rights trade on Euronext Paris from 16 to 25 November 2026. Subscriptions run from 18 to 27 November 2026, and brokers may set earlier deadlines.

What happens if I do nothing with my Eramet rights?

They lapse automatically at the close of trading on 27 November 2026 and become worthless.

Sources

Related stories

Investing

Bannerman Energy Profile: Building Namibia's Etango Uranium Mine With a CNNC Partner

Bannerman Energy is building the Etango uranium mine in Namibia with CNNC's overseas arm. Its cash, share count, mine plan, sales terms and the dates to watch before first output…

Investing

Warren Buffett Gives 9.2 Million Berkshire Shares to Four Family Foundations at Thanksgiving

Warren Buffett, 96, is giving 9,225,000 Berkshire B shares to four family foundations, over three times last year's gift, and says his confidence in Berkshire is as strong as ever.

Investing

FDA Rejects Summit's Lung Cancer Drug Ivonescimab Over Phase 3 Survival Miss

The FDA has rejected Summit Therapeutics' lung cancer drug ivonescimab, saying slower tumour growth in the phase 3 HARMONi trial was not enough without a clear gain in survival.

Investing

Red Cat Withdraws Its $150m to $180m 2026 Revenue Target After $11.8m Third Quarter

Red Cat Holdings has withdrawn its $150m to $180m revenue target for 2026 after third-quarter sales of $11.8m, blaming slower defence funding. Its quarterly net loss more than…

Investing

Aya Gold & Silver Corrects Q3 Cash Costs to $14.28 an Ounce After Silver Double Count

Aya Gold & Silver refiled its Q3 MD&A after silver in transit was deducted twice. Zgounder ounces sold rise to 1,392,478 and cash costs fall to $14.28 from $15.51. Revenue and…

Investing

FDA Rejects Summit's Lung Cancer Drug Ivonescimab Over Phase 3 Survival Miss

The FDA has rejected Summit Therapeutics' lung cancer drug ivonescimab, saying slower tumour growth in the phase 3 HARMONi trial was not enough without a clear gain in survival.

Investing

Red Cat Withdraws Its $150m to $180m 2026 Revenue Target After $11.8m Third Quarter

Red Cat Holdings has withdrawn its $150m to $180m revenue target for 2026 after third-quarter sales of $11.8m, blaming slower defence funding. Its quarterly net loss more than…

Investing

Berkshire Reveals $689m Bending Spoons Stake, Doubles Lennar and Trims Bank of America Again

Berkshire Hathaway's third-quarter 13F shows a new Bending Spoons stake worth $689m, a doubled Lennar holding and 27.5 million more Bank of America shares sold, while Apple stayed…